Evidence map›Paper›PMID 28130654›Full record

ReviewCurrent atherosclerosis reports2017

The Genetic Architecture of Coronary Artery Disease: Current Knowledge and Future Opportunities.

Jaana Hartiala, William S Schwartzman, Julian Gabbay, Anatole Ghazalpour, Brian J Bennett, Hooman Allayee

Abstract readReview
In one paragraph

Review in Current atherosclerosis reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Exome sequencing identifies rare mutations ofNational science review · 2022
    Article
  8. Article
  9. Article
  10. Gene-Environment Interactions for Cardiovascular Disease.Current atherosclerosis reports · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Genetic Markers for Coronary Artery Disease.Medicina (Kaunas, Lithuania) · 2018
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jaana HartialaDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA, 90033, USA.
William S SchwartzmanDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA, 90033, USA.
Julian GabbayDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA, 90033, USA.
Anatole GhazalpourDepartment of Human Genetics, David Geffen School of Medicine of UCLA, Los Angeles, CA, 90095, USA.
Brian J BennettUSDA Western Human Nutrition Research Center, University of California Davis, Davis, CA, 95616, USA.
Hooman AllayeeDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA, 90033, USA. hallayee@usc.edu.
University of Southern California · USUniversity of California, Davis · USUniversity of California, Los Angeles · US

Funding

Southern California Children's Environmental Health Center (SC-CEHC)P01ES022845 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MCCONNELL, ROB S · 2013 to 2018
$4.0M
INTEGRATIVE GENETIC APPROACHES TO GENE-AIR POLLUTION INTERACTIONS IN ASTHMAR01ES021801 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI AKBARI, OMID, ALLAYEE, HOOMAN · 2012 to 2016
$3.9M
Nutrigenetic Intervention to Reduce Liver Fat in Hispanics - SupplementR01MD010358 · NIMHD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GORAN, MICHAEL ISAAC · 2016 to 2019
$3.3M
Role of Glycine Metabolism in Cardiovascular DiseaseR01HL133169 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ALLAYEE, HOOMAN · 2017 to 2020
$3.3M
Genetic and Environmental Determinants of Asthma EndophenotypesR01ES025786 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI AKBARI, OMID, ALLAYEE, HOOMAN · 2015 to 2019
$2.8M
Systems Genetic Studies of TMAO regulation and AtherosclerosisR01HL128572 · NHLBI · U.S. AGRICULTURAL RESEARCH SERVICE · PI BENNETT, BRIAN JOSEPH · 2015 to 2019
$1.4M
NHLBI NIH HHS R01 HL128572NHLBI NIH HHS R01 HL133169NIEHS NIH HHS P01 ES022845NIEHS NIH HHS R01 ES021801NIEHS NIH HHS R01 ES025786NIMHD NIH HHS R01 MD010358
6 · The paper itself

Abstract

purpose of reviewWe provide an overview of our current understanding of the genetic architecture of coronary artery disease (CAD) and discuss areas of research that provide excellent opportunities for further exploration. RECENT

findingsLarge-scale studies in human populations, coupled with rapid advances in genetic technologies over the last decade, have clearly established the association of common genetic variation with risk of CAD. However, the effect sizes of the susceptibility alleles are for the most part modest and collectively explain only a small fraction of the overall heritability. By comparison, evidence that rare variants make a substantial contribution to risk of CAD has been somewhat disappointing thus far, suggesting that other biological mechanisms have yet to be discovered. Emerging data suggests that novel pathways involved in the development of CAD can be identified through complementary and integrative systems genetics strategies in mice or humans. There is also convincing evidence that gut bacteria play a previously unrecognized role in the development of CAD, particularly through metabolism of certain dietary nutrients that lead to proatherogenic metabolites in the circulation. A major effort is now underway to functionally understand the newly discovered genetic and biological associations for CAD, which could lead to the development of potentially novel therapeutic strategies. Other important areas of investigation for understanding the pathophysiology of CAD, including epistatic interactions between genes or with either sex and environmental factors, have not been studied on a broad scope and represent additional opportunities for future studies.

Indexed as

AllelesAnimalsCoronary Artery DiseaseGenetic Predisposition to DiseaseGenetic VariationGenome-Wide Association StudyHumansRisk FactorsCoronary artery diseaseGene-environment interactionsGenome-wide association studyMetabolomicsMicrobiomeRare variants

Identifiers

PMID28130654
PMCPMC5783155
OpenAlexW2581910088

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.